AbbVie Inc. (ABBV) operating KPIs
ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$294.89+4.10 (+1.41%)
Close on Oct 30, 2026Market cap $521.11BP/E 83.3Yield 2.26%
Latest, FY2025
52,641
Period ended Dec 31, 2025
Change on a year earlier
-12.4%
60,068 in FY2024
History
14 years
Since FY2012
Sources
14
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Intangible assets, net ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 52,641 | -12.4% | Form 10-K (filed 2026-02-20) ↗ |
| FY2024 | Dec 31, 2024 | 60,068 | +8.0% | Form 10-K (filed 2025-02-14) ↗ |
| FY2023 | Dec 31, 2023 | 55,610 | -17.5% | Form 10-K (filed 2024-02-20) ↗ |
| FY2022 | Dec 31, 2022 | 67,439 | -11.2% | Form 10-K (filed 2023-02-17) ↗ |
| FY2021 | Dec 31, 2021 | 75,951 | -8.4% | Form 10-K (filed 2022-02-18) ↗ |
| FY2020 | Dec 31, 2020 | 82,876 | +344.4% | Form 10-K (filed 2021-02-19) ↗ |
| FY2019 | Dec 31, 2019 | 18,649 | -12.2% | Form 10-K (filed 2020-02-21) ↗ |
| FY2018 | Dec 31, 2018 | 21,233 | -23.0% | Form 10-K (filed 2019-02-27) ↗ |
| FY2017 | Dec 31, 2017 | 27,559 | -4.6% | Form 10-K (filed 2018-02-16) ↗ |
| FY2016 | Dec 31, 2016 | 28,897 | +46.6% | Form 10-K (filed 2017-02-17) ↗ |
| FY2015 | Dec 31, 2015 | 19,709 | +1,202.6% | Form 10-K (filed 2016-02-19) ↗ |
| FY2014 | Dec 31, 2014 | 1,513 | -19.9% | Form 10-K (filed 2015-02-20) ↗ |
| FY2013 | Dec 31, 2013 | 1,890 | -18.6% | Form 10-K (filed 2014-02-21) ↗ |
| FY2012 | Dec 31, 2012 | 2,323 | – | Form 10-Q (filed 2013-05-08) ↗ |
Cite this data
StockData. (2026). AbbVie Intangible assets, net ($M) ($M), annual FY2012–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/fs_intang
See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.